WHO inks deal for delivery of Pfizer-BioNTech vaccines in poor countries
The availability of vaccines to lower-income countries and help bring a rapid end to the acute stage of the Covid-19 pandemic24-01-2021
24-01-2021
Covax on track as pact signed with Pfizer/BioNTech for 40 million doses
Vaccines from AZ-Oxford, SII in the pipeline23-01-2021
Pfizer will ship fewer vaccine vials to account for extra' doses
The distinction was critical: Pfizer's contract with the federal government requires that it be paid by the dose. And there were serious public health implications. If the label's formal language told people administering the vaccine that the vial contained a sixth dose, that could accelerate the pace of vaccinations at a crucial time.23-01-2021
Pfizer-BioNTech agree to supply COVID-19 vaccines to COVAX alliance
Details on the size of the deal or the price per dose COVAX would pay were not immediately clear, but the sources said the allotment would likely be relatively small22-01-2021
Japan to start coronavirus vaccinations with Pfizer vaccines
Kono told reporters the next priority after medical workers was to vaccinate the elderly, those with health conditions and elderly care facility workers.22-01-2021
Pfizer-BioNTech shot may neutralise mutating coronavirus, study shows
The new research tested all 10 mutations located on the virus's spike protein, which helps it bind to cells in the host20-01-2021
WHO close to sealing Pfizer deal to give poorer countries access to vaccines
The COVAX scheme -- led by the WHO and GAVI vaccine alliance -- is due to start rolling out vaccines to poor and middle-income countries in February, with 2 of 3 billion doses expected to be delivered this year19-01-2021
Pfizer vaccine worries Norway as 29 elderly people die after taking shot
The latest figure adds six to the number of known fatalities in Norway, and lowers the age group thought to be affected to 75 from 8017-01-2021
Serum Institute Awaits WHO Emergency Approval For AstraZeneca Shot Soon
The World Health Organization (WHO) listed Pfizer and BioNTech's Covid-19 shot for emergency use on December 31 as it sought to accelerate vaccination in the developing world, which is badly...14-01-2021